Cardinal Health's Board of Directors approved an increase in the quarterly dividend to $0.5158 per share, to be paid on July 15, 2026, to shareholders recorded by July 1, 2026. The dividend will be paid out of the company's capital surplus. This move reflects Cardinal Health's ongoing commitment to returning value to shareholders amid its operations in pharmaceutical distribution and medical products. Investors can expect the dividend increase as a sign of the company's financial health and shareholder focus.
Cardinal Health received a Buy rating due to its defensive business model, strong adjusted EPS growth of 35% in Q3FY26, and strategic moves into specialty healthcare. The company reported 11% revenue growth, though GAAP earnings were pressured by hig...
The global gauze bandage rolls market, valued at $1.96 billion in 2025, is projected to grow to $3.19 billion by 2035 at a CAGR of 4.97%. Growth is fueled by increasing surgeries, chronic wound care needs, and demand for advanced antimicrobial produc...
The global gauze bandage rolls market, valued at $1.96 billion in 2025, is projected to grow to $3.19 billion by 2035 at a CAGR of 4.97%. Growth is driven by increased surgeries, chronic wounds, and demand for advanced antimicrobial products, especia...
